Sarepta Therapeutics Inc (NASDAQ: SRPT) kicked off on Monday, down -5.36% from the previous trading day, before settling in for the closing price of $14.07. Over the past 52 weeks, SRPT has traded in a range of $12.81-$150.48.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded -279.05%. With a float of $93.47 million, this company’s outstanding shares have now reached $98.25 million.
Considering the fact that the conglomerate employs 1372 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 80.96%, operating margin of -5.25%, and the pretax margin is -7.35%.
Sarepta Therapeutics Inc (SRPT) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Sarepta Therapeutics Inc is 4.89%, while institutional ownership is 90.37%. The most recent insider transaction that took place on Mar 12 ’25, was worth 248,203. In this transaction Director of this company sold 2,491 shares at a rate of $99.64, taking the stock ownership to the 27,812 shares. Before that another transaction happened on Mar 12 ’25, when Company’s Director proposed sale 2,491 for $99.65, making the entire transaction worth $248,226.
Sarepta Therapeutics Inc (SRPT) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.35 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -279.05% per share during the next fiscal year.
Sarepta Therapeutics Inc (NASDAQ: SRPT) Trading Performance Indicators
Take a look at Sarepta Therapeutics Inc’s (SRPT) current performance indicators. Last quarter, stock had a quick ratio of 2.46. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.59.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.58, a number that is poised to hit 0.78 in the next quarter and is forecasted to reach 2.53 in one year’s time.
Technical Analysis of Sarepta Therapeutics Inc (SRPT)
Compared to the last year’s volume of 4.33 million, its volume of 28.19 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 34.52%.
During the past 100 days, Sarepta Therapeutics Inc’s (SRPT) raw stochastic average was set at 0.74%, which indicates a significant decrease from 7.02% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.60 in the past 14 days, which was lower than the 3.05 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $28.60, while its 200-day Moving Average is $85.28.
